---
document_datetime: 2023-09-21 18:32:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/envarsus-epar-all-authorised-presentations_en.pdf
document_name: envarsus-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3629298
conversion_datetime: 2025-12-31 01:24:34.833158
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EU Number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

EU/1/14/935/001

EU/1/14/935/002

EU/1/14/935/003

EU/1/14/935/004

EU/1/14/935/005

EU/1/14/935/006

EU/1/14/935/007

EU/1/14/935/008

EU/1/14/935/009

Envarsus

Envarsus

Envarsus

Envarsus

Envarsus

Envarsus

Envarsus

Envarsus

Envarsus

0.75 mg

0.75 mg

0.75 mg

1 mg

1 mg

1 mg

4 mg

4 mg

4 mg

Prolonged-release tablet

Prolonged-release tablet

Prolonged-release tablet

Prolonged-release tablet

Prolonged-release tablet

Prolonged-release tablet

Prolonged-release tablet

Prolonged-release tablet

Prolonged-release tablet

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use blister (PVC/alu)

blister (PVC/alu)

blister (PVC/alu)

blister (PVC/alu)

blister (PVC/alu)

blister (PVC/alu)

blister (PVC/alu)

blister (PVC/alu)

blister (PVC/alu)

30 tablets

60 tablets

90 tablets

30 tablets

60 tablets

90 tablets

30 tablets

60 tablets

90 tablets